Add BrightSurf on Google Email

Unlocking the mystery behind Barrett’s esophagus

A study by Baylor College of Medicine reveals that altered genes SOX2 and CDX2 drive Barrett's esophagus formation. The team created organoids from patient tissue, showing that the balance between these genes determines cell identity. This new understanding supports earlier intervention and diagnosis for this potentially deadly cancer.

SourceBaylor College of Medicine·JournalJournal of Clinical Investigation·TypeExperimental study·DateJul 2, 2025

Mount Sinai researchers use wearable technology to explore the link between IBD and sleep disruption

The study found that significant changes in sleep metrics occurred only when inflammation was present in the body, with symptoms alone not resulting in any notable sleep disruption. Sleep disturbances worsened leading up to inflammatory flares and improved afterward, suggesting that sleep changes may signal upcoming disease activity.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalClinical Gastroenterology and Hepatology·DateJun 26, 2025

New ASU research hunts down drug-resistant microbes

Researchers from ASU and international collaborators tested a handheld DNA sequencing device at six chicken slaughterhouses in Indonesia. The study found signs of antibiotic-resistant bacteria spreading from wastewater into nearby rivers, highlighting the need for targeted solutions to reduce its spread.

SourceArizona State University·JournalAntibiotics·TypeObservational study·DateJun 26, 2025

Canine genes offer clues to gastric cancer in humans

Researchers used canine DNA to identify over 15 genes linked to gastric cancer in humans, offering promising new avenues for research. The study suggests genetic testing could help diagnose the disease earlier and guide breeding decisions to reduce disease prevalence.

SourceCornell University·JournalProceedings of the National Academy of Sciences·DateJun 2, 2025

ASCO 2025: Pancreatic cancer blood tests, genetic predictors of breast cancer survival and sarcoma treatment response prediction tools among Ohio State findings

Researchers at Ohio State University have developed blood tests to diagnose pancreatic cancer and predict treatment outcomes. Genetic information can also help predict breast cancer survival rates, while a new blood test may improve treatment response for patients with advanced sarcoma. These findings offer promising tools for early de...

Experimental Drug Development Centre granted US FDA fast track designation for antibody-drug conjugate EBC-129 to treat pancreatic ductal adenocarcinoma

The Experimental Drug Development Centre's EBC-129, an antibody-drug conjugate targeting pancreatic cancer, has received FDA fast track designation. The treatment is undergoing Phase 1 clinical trials and aims to provide new treatment options for patients with solid tumours.

Research collaboration charts global four-stage evolution of inflammatory bowel disease

Researchers from UCalgary and Chinese University of Hong Kong found that IBD progresses through four predictable epidemiological stages as it spreads globally. The study forecasts a major rise in IBD prevalence in Canada by 2045, with countries in North America, Europe, and Oceania reaching Stage 3 (compounding prevalence). Developing ...

SourceUniversity of Calgary·JournalNature·TypeMeta-analysis·DateApr 30, 2025

New way to prevent duodenal cancer

Bonn researchers found higher numbers of type 3 innate lymphoid cells in duodenum tissue of FAP patients, producing interleukin-17A which stimulates ROS production and DNA damage. This suggests a local environment favoring cancer development, prompting a new approach to preventing duodenal cancer.

SourceUniversitatsklinikum Bonn·JournalNature Communications·DateApr 25, 2025

Research Spotlight: Comparison of single-cell profiling methods reveals strengths and limitations

The study directly compared Droplet-based scRNA (D-scRNA) and Picowell-based scRNA (P-scRNA) platforms for analyzing human mucosal biopsies. D-scRNA provides more detailed insights, but requires resources and may introduce contamination. P-scRNA is gentler, more resource-efficient, but less effective in capturing rare cell types.

SourceBrigham and Women's Hospital·JournalCellular and Molecular Gastroenterology and Hepatology·TypeObservational study·DateApr 14, 2025

Research uncovers hidden spread of one of the most common hospital-associated infections

A new study found that Clostridium difficile infection spreads more than three times more than previously thought within intensive care units, with bacteria moving between patients and hospital surfaces. The researchers tracked bacterial movement using whole genome DNA sequencing and discovered cases of potential transmission that woul...

SourceUniversity of Utah Health·JournalJAMA Network Open·TypeObservational study·DateApr 4, 2025

A probiotic bacterial strain proven more effective for treating a common intestinal infection

Researchers have discovered a new probiotic bacterial strain that is 15% more effective in treating giardiasis than the existing strain. The strain, Lactobacillus johnsonii CNCM I-4884, has significant anti-Giardia activity and can transform conjugated bile salts into toxic compounds for the parasite.

Novel genes linked to rare childhood diarrhea

Researchers at SickKids identified three new genes associated with rare childhood diarrhea, providing a diagnosis for 48% of cases. The study found that genetic testing and targeted treatments can improve the quality of life for children like Sophie, who was diagnosed with CODE at just two days old.

SourceThe Hospital for Sick Children·JournalNew England Journal of Medicine·DateApr 2, 2025

Impaired gastric myoelectrical rhythms associated with altered autonomic functions in patients with severe ischemic stroke

Patients with severe ischemic stroke show impaired gastric motility and autonomic dysfunction, with reduced normal gastric slow waves and increased sympathetic activity. These findings suggest a link between gastric myoelectrical rhythms and autonomic function in ischemic stroke.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateMar 17, 2025

Wireless ingestible capsule detects 'Leaky Gut' in real-time

A team of researchers has developed an ingestible bioimpedance sensing device that continuously monitors gastrointestinal mucosal barrier integrity wirelessly. The device can detect subtle changes in mucosal permeability, a common feature in Inflammatory Bowel Disease (IBD), enabling early detection and improved diagnosis.

ASTRO issues its first clinical guideline on radiation therapy for anal cancer

The American Society for Radiation Oncology (ASTRO) has published its first clinical guideline on radiation therapy for anal cancer, providing guidance on treatment options and techniques. The guideline recommends a combination of radiation therapy and drug therapy as the standard of care, with intensity-modulated radiation therapy (IM...

SourceAmerican Society for Radiation Oncology·JournalPractical Radiation Oncology·DateFeb 27, 2025

Stalled microbiomes: Dartmouth-led study reveals that cystic fibrosis disrupts early gut development in infants

A Dartmouth-led study reveals that cystic fibrosis disrupts the maturation of the gut microbiome in infants, leading to a depletion of health-associated bacteria and potentially poor health outcomes. The study found that the microbiomes of infants with CF remained stunted or delayed in their development compared to healthy infants.

NUS scientists develop realistic ‘micro-gut’ model to study the relationship between gut microbes and human diseases

Researchers developed a 3D microscopic version of the human intestines on a chip, allowing for real-time examination of gut microbes' interactions with the human intestine. The 'Gut-Microbiome on a chip' model enables the study of complex interplay between gut microbes and health, facilitating targeted microbiome-based interventions.

SourceNational University of Singapore·JournalAdvanced Science·TypeExperimental study·DateFeb 9, 2025

Extracellular vesicles may be the key to developing safer and more effective therapies for inflammatory bowel disease

Researchers have reviewed the therapeutic potential of extracellular vesicles derived from mesenchymal stem cells in treating inflammatory bowel disease. The study highlights the immunomodulatory, pro-regenerative, and anti-apoptotic properties of these vesicles, which may offer a safer alternative to conventional therapies.

SourceGermans Trias i Pujol Research Institute·JournalClinical and Translational Medicine·TypeLiterature review·DateNov 20, 2024